Aravive Inc. (NASDAQ:ARAV) finished Thursday with a subtraction of $0.0 to close at $0.22, an upside of 2.43 percent. An average of 12,944,900 shares of common stock have been traded in the last five days. There was a fall of -$0.0663 in the past week, and it reached a new high 9 times over the past 12 months. The last 20 days have seen an average of 5,960,225 shares traded, while the 50-day average volume stands at 2,585,748.
ARAV stock has decreased by -85.49% in the last month. The company shares reached their 1-month lowest point of $0.2071 on 08/09/23. With the stock rallying to its 52-week high on 03/21/23, shares of the company touched a low of $0.21 and a high of $2.46 in 52 weeks. It has reached a new high 11 times so far this year and lost -83.07% or -$1.0965 in price. In spite of this, the price is down -90.91% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
Aravive Inc. (ARAV) stock’s beta is 2.43. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.61.
Financial Health
The quick ratio of Aravive Inc. for the three months ended March 30 was 1.90, and the current ratio was 1.90, indicating that the company is able to meet its debt obligations. Aravive Inc.’s EBITDA margin for the year ending March 30 is -765.58%. Its gross profit as reported stood at $79.97 million compared to revenue of $9.14 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Aravive Inc.’s return on assets was -222.80%.
Earnings Surprise
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$49.96 million in the quarter, while revenues of -$29.13 million were grew 73.86%. The analyst consensus anticipated Aravive Inc.’s latest quarter earnings to come in at -$0.32 per share, but it turned out to be -$0.66, a -106.20% surprise. For the quarter, EBITDA amounted to -$17.7 million. Shareholders own equity worth $59.84 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Aravive Inc. (ARAV) price momentum. RSI 9-day as of the close on 10 August was 10.15%, suggesting the stock is oversold, with historical volatility in this time frame at 700.59%.
As of today, ARAV’s price is $0.2337 -22.88% or -$0.0663 from its 5-day moving average. ARAV is currently trading -86.45% lower than its 20-day SMA and -88.60% lower than its 100-day SMA. However, the stock’s current price level is -86.29% below the SMA50 and -72.91% below the SMA200.
The stochastic %K and %D were 0.93% and 1.18%, respectively, and the average true range (ATR) was 0.1397. With the 14-day stochastic at 1.10% and the average true range at 0.1438, the RSI (14) stands at 15.62%. The stock has reached -0.3823 on the 9-day MACD Oscillator while the 14-day reading was at -0.6716.
Analyst Ratings
The consensus rating for Aravive Inc. (ARAV) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell ARAV, while 3 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 2 others rate it as a “buy”.
What is ARAV’s price target for the next 12 months?
Analysts predict a range of price targets between $10.00 and $18.00, with a median target of $12.00. Taking a look at these predictions, the average price target given by analysts for Aravive Inc. (ARAV) stock is $13.33.
